Other
Other Income (Expense)
West Pharmaceutical Services Other Income (Expense) increased by 78.4% to -$4.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 80.6%, from -$20.60M to -$4.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 59.6% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Large fluctuations indicate non-recurring events that may distort the view of underlying operational performance.
Detailed definition
This category captures miscellaneous income or expenses that are not part of the company's core operating activities. It...
Peer comparison
Often excluded by analysts when calculating 'adjusted' earnings to focus on core business trends.
Metric ID:
other_other_income_expense_9d6555Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.70M | -$1.80M | -$4.90M | $3.10M | $2.80M | -$1.90M | -$30.80M | -$12.90M | -$4.00M | -$5.60M | -$8.90M | -$3.10M | -$3.30M | -$4.40M | -$10.20M | -$20.60M | -$5.20M | -$6.90M | -$18.50M | -$4.00M |
| QoQ Change | — | -166.7% | -172.2% | +163.3% | -9.7% | -167.9% | <-999% | +58.1% | +69.0% | -40.0% | -58.9% | +65.2% | -6.5% | -33.3% | -131.8% | -102.0% | +74.8% | -32.7% | -168.1% | +78.4% |
| YoY Change | — | — | — | — | +3.7% | -5.6% | -528.6% | -516.1% | -242.9% | -194.7% | +71.1% | +76.0% | +17.5% | +21.4% | -14.6% | -564.5% | -57.6% | -56.8% | -81.4% | +80.6% |
Range-$30.80M – $3.10M
CAGR+8.6%
Avg YoY Growth-124.5%
Median YoY Growth-35.7%
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other income (expense)?
- West Pharmaceutical Services (WST) reported other income (expense) of -$4.00M in Q1 2026.
- How has West Pharmaceutical Services's other income (expense) changed year-over-year?
- West Pharmaceutical Services's other income (expense) increased by 80.6% year-over-year, from -$20.60M to -$4.00M.
- What is the long-term trend for West Pharmaceutical Services's other income (expense)?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's other income (expense) has grown at a 59.6% compound annual growth rate (CAGR), from -$7.90M to -$51.20M.
- What does other income (expense) mean?
- Incidental income or expenses not related to core business operations.